DGAP-News: Apricus Biosciences to Present at BIO-Europe Spring 2013
(firmenpresse) - Apricus Biosciences, Inc.
07.03.2013 14:00
---------------------------------------------------------------------------
SAN DIEGO, 2013-03-07 14:00 CET (GLOBE NEWSWIRE) --
Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI)
(www.apricusbio.com) announced today that Edward Cox, Vice President Corporate
Development&Investor Relations, will present at the BIO-Europe Spring 2013
Partnering Conference, being held in Barcelona, Spain. Mr. Cox's presentation
will take place on Wednesday, March 13, 2013 at 11:00 a.m. Local Time (6:00
a.m. Eastern Time).
A replay of the presentation will be accessible to the public online at the
Company's website at http://www.apricusbio.com.
About Apricus Biosciences, Inc.
Apricus Biosciences, Inc. is a pharmaceutical company that develops and markets
innovative treatments that help large patient populations across numerous,
large-market therapeutic classes including male and female sexual health. The
Company has one approved product, Vitaros(r), for the treatment of erectile
dysfunction, which will be marketed in Canada by Abbott Laboratories and
Femprox(r), a product candidate, for the treatment of female sexual arousal
disorder, which successfully completed one 400-patient Phase III study in
China.
For further information on Apricus Bio, visit http://www.apricusbio.com. You
can also receive information at http://twitter.com/apricusbio.
CONTACT: Apricus Bio Investor Relations:
David Pitts
Argot Partners
212-600-1902
david(at)argotpartners.com
News Source: NASDAQ OMX
07.03.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Apricus Biosciences, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9901429525
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Pazoo Unveils New Logo Becoming the Recognizable Symbol of Pazoo Now And Into The Future
Datum: 07.03.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 237066
Anzahl Zeichen: 7572
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 222 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Apricus Biosciences to Present at BIO-Europe Spring 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Apricus Biosciences, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
